https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-16 / Eur J Cancer 2021 Oct;158:123-132
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-16 / Eur J Cancer 2021 Oct;158:123-1322021-10-16 00:00:002021-10-16 00:00:00Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-09 / J Clin Oncol 39, 2021 (suppl 15; abstr 11542)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-09 / J Clin Oncol 39, 2021 (suppl 15; abstr 11542)2021-08-09 09:41:192021-08-09 09:41:19Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-11-14 / Front Oncol 2019;9:1169
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-11-14 / Front Oncol 2019;9:11692019-11-14 00:00:002019-11-14 00:00:00Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-23 / Cancer Gene Ther. 2019 09;26(9-10):282-291
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-23 / Cancer Gene Ther. 2019 09;26(9-10):282-2912019-01-23 00:00:002019-01-23 00:00:00Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-04-01 / JAMA Oncol 2018 Apr;4(4):483-492
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-04-01 / JAMA Oncol 2018 Apr;4(4):483-4922018-04-01 00:00:002019-02-15 09:37:56Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-03-01 / Tumori 2015 Mar-Apr;101(2):e54-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-03-01 / Tumori 2015 Mar-Apr;101(2):e54-62015-03-01 00:00:002019-02-15 09:37:55Concomitant trimodality therapy of re-irradiation, chemotherapy and regional hyperthermia for a pretreated inoperable sarcoma recurrence
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-02-26 / J. Nucl. Med. 2015 Apr;56(4):530-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-02-26 / J. Nucl. Med. 2015 Apr;56(4):530-72015-02-26 00:00:002019-02-15 09:37:54PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)2013-06-03 00:00:002021-08-09 07:55:21Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-28 / Cancer 2012 Jan;118(1):180-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-28 / Cancer 2012 Jan;118(1):180-72011-06-28 00:00:002011-06-28 00:00:00Reirradiation and hyperthermia for radiation-associated sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 9541)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 9541)2011-06-05 00:00:002011-06-05 00:00:00Pilot immunotherapy trial in high-risk pediatric sarcomas.
